Bokus

David A. Fishman – författare

Visar alla böcker från författaren David A. Fishman. Handla med fri frakt och snabb leverans.

4 produkter

  1. M. Sharon Stack, David A. Fishman - Ovarian Cancer, Inbunden. Tillgänglighet: Lägg i varukorg

    Ovarian Cancer

    Second Edition

    Av M. Sharon Stack, David A. Fishman

    Inbunden, 2009

    1689 kr

    Lägg i varukorg

    Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, …

  2. David A. Fishman, M. Sharon Stack - Ovarian Cancer, E-bok. Tillgänglighet: Lägg i varukorg

    Ovarian Cancer

    Second Edition

    Av David A. Fishman, M. Sharon Stack

    E-bok, 2009

    1634 kr

    Lägg i varukorg

    Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, …

  3. M. Sharon Stack, David A. Fishman - Ovarian Cancer, Häftad. Tillgänglighet: Lägg i varukorg

    Ovarian Cancer

    Second Edition

    Av M. Sharon Stack, David A. Fishman

    Häftad, 2012

    1243 kr

    Lägg i varukorg

    Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, …

  4. David A. Fishman, M. Sharon Stack - Ovarian Cancer, E-bok. Tillgänglighet: Lägg i varukorg

    Ovarian Cancer

    Av David A. Fishman, M. Sharon Stack

    E-bok, 2013

    1209 kr

    Lägg i varukorg

    Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, …